Leveraging Innovation To Deliver Precision Medicines

News & Events

Press Releases

24 November 2020

Jubilant Therapeutics Announces Upcoming Presentation at 2020 ASH Virtual Annual Meeting

12 November 2020

Jubilant Therapeutics and OneThree Biotech Collaborate to Advance Precision Oncology

04 November 2020

Jubilant Therapeutics to Participate in Upcoming Investor Conferences

20 October 2020

Jubilant Therapeutics Strengthens Scientific Advisory Board

22 June 2020

Jubilant Therapeutics Presents Preclinical Data at the American Association for Cancer Research, Reveals Unique Dual-Action Anti-Cancer Mechanism Underscoring First-in-Class Pipeline Asset in Hematological Tumors

We use cookies to recognize your repeat visits and preferences, as well as to measure the effectiveness
of campaigns and analyze traffic. If you continue to use this site we will assume your acceptance.